Gastroenterology

Special Pilot/Feasibility Funding Opportunity

Special Pilot/Feasibility Funding Opportunity

Posted by  | Research

The funding for the pilot/feasibility project is available from the Hopkins Conte Digestive Diseases Basic and Translational Research Core Center. The amount of this P/F is up to $25,000. The main goal is to perform GI-related research involving advanced imaging that uses instrumentation provided in Olympus Demonstration Unit on Ross 9 floor. Funding is for(...)

Read More

Sateia named Core Advisor for the Colleges Advisory Program

Sateia named Core Advisor for the Colleges Advisory Program

Posted by  | Congratulations

Congratulations to Heather Sateia, instructor in the Division of General Internal Medicine, on her selection as a core advisor for the School of Medicine’s Colleges Advisory Program. In this role, Dr. Sateia will serve as one of 23 core advisors and clinical skills teachers for the medical students, greatly impacting medical student growth. This is a highly(...)

Read More

U.S. News and World Report Annual Rankings

U.S. News and World Report Annual Rankings

Posted by  | Congratulations

Once again Hopkins was ranked among the best hospitals in the country, receiving the third slot on U.S. News & World Report’s annual Best Hospital’s list. A contributing factor among the success of the hospital are the seven specialties within the Department of Medicine that were ranked some of the best nationwide. Please join us(...)

Read More

Institute for Clinical & Translational Research Pilot Awards

Posted by  | Congratulations, Research

Pilot awards to catalyze new research collaborations are a key component of the Johns Hopkins Medicine Strategic Plan. With institutional financial support and the leadership of the Johns Hopkins Medicine Research Council, the Institute for Clinical & Translational Research has reviewed the 2015 Discovery Fund applications from faculty members reflecting the full spectrum of research(...)

Read More

Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage

Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage

Posted by  | Article of the Week

ARTICLE: Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage AUTHOURS: Yulan Cheng, Ana P. Kiess, Joseph M. Herman, Martin G. Pomper, Stephen J. Meltzer, John M. Abraham JOURNAL: PLoS One. 2015 Jun 1;10(6):e0128152. doi: 10.1371/journal.pone.0128152. eCollection 2015. Abstract Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill(...)

Read More